Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 971

1.

Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).

Ramiro S, Landewé RB, van der Heijde D, Sepriano A, FitzGerald O, Ostergaard M, Homik J, Elkayam O, Thorne JC, Larche M, Ferraciolli G, Backhaus M, Boire G, Combe B, Schaeverbeke T, Saraux A, Dougados M, Rossini M, Govoni M, Sinigaglia L, Cantagrel AG, Allaart CF, Barnabe C, Bingham CO, Tak PP, van Schaardenburg D, Hammer HB, Dadashova R, Hutchings E, Paschke J, Maksymowych WP.

Ann Rheum Dis. 2020 Feb 24. pii: annrheumdis-2019-216819. doi: 10.1136/annrheumdis-2019-216819. [Epub ahead of print]

PMID:
32094157
2.

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.

Sepriano A, Kerschbaumer A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JW, Burmester GR, de Wit M, Falzon L, Landewé R.

Ann Rheum Dis. 2020 Feb 7. pii: annrheumdis-2019-216653. doi: 10.1136/annrheumdis-2019-216653. [Epub ahead of print]

PMID:
32033941
3.

Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.

Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JWJ, Burmester GR, de Wit M, Falzon L, Landewé R.

Ann Rheum Dis. 2020 Feb 7. pii: annrheumdis-2019-216656. doi: 10.1136/annrheumdis-2019-216656. [Epub ahead of print]

4.

What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts.

Sepriano A, Ramiro S, van der Heijde D, van Gaalen F, Hoonhout P, Molto A, Saraux A, Ramonda R, Dougados M, Landewé R.

Ann Rheum Dis. 2020 Mar;79(3):324-331. doi: 10.1136/annrheumdis-2019-216516. Epub 2020 Jan 24.

PMID:
31980546
5.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.

Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D.

Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis-2019-216655. doi: 10.1136/annrheumdis-2019-216655. [Epub ahead of print]

6.

Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry.

Morel J, Locci M, Banal F, Combe B, Cormier G, Dougados M, Flipo RM, Marcelli C, Pham T, Rist S, Solau Gervais E, Sibilia J, Lukas C.

Clin Exp Rheumatol. 2020 Jan 20. [Epub ahead of print]

PMID:
31969215
7.

Dactylitis in early spondyloarthritis. Data from the prospective French national cohort DESIR.

Wendling D, Prati C, Saraux A, Molto A, Pham T, Dougados M, Guillot X.

Joint Bone Spine. 2020 Jan 17. pii: S1297-319X(20)30005-1. doi: 10.1016/j.jbspin.2020.01.003. [Epub ahead of print] No abstract available.

PMID:
31958574
8.

Treat to target in axial spondyloarthritis: From its concept to its implementation.

Dougados M.

J Autoimmun. 2020 Jan 8:102398. doi: 10.1016/j.jaut.2019.102398. [Epub ahead of print] Review.

9.

Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study.

Dougados M, van der Heijde D, Tsai WC, Saaibi D, Marshall L, Jones H, Pedersen R, Vlahos B, Tarallo M.

Health Qual Life Outcomes. 2020 Jan 3;18(1):4. doi: 10.1186/s12955-019-1260-4.

10.

Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis.

López-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A.

RMD Open. 2019 Nov 21;5(2):e001108. doi: 10.1136/rmdopen-2019-001108. eCollection 2019.

11.

Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohort.

López-Medina C, Molto A, Claudepierre P, Dougados M.

Ann Rheum Dis. 2020 Feb;79(2):209-216. doi: 10.1136/annrheumdis-2019-216218. Epub 2019 Nov 29.

PMID:
31784451
12.

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W).

Dougados M, Wei JC, Landewé R, Sieper J, Baraliakos X, Van den Bosch F, Maksymowych WP, Ermann J, Walsh JA, Tomita T, Deodhar A, van der Heijde D, Li X, Zhao F, Bertram CC, Gallo G, Carlier H, Gensler LS; COAST-V and COAST-W Study Groups.

Ann Rheum Dis. 2020 Feb;79(2):176-185. doi: 10.1136/annrheumdis-2019-216118. Epub 2019 Nov 4.

13.

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.

Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

RMD Open. 2019 Sep 19;5(2):e001041. doi: 10.1136/rmdopen-2019-001041. eCollection 2019.

14.

Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study.

Stolwijk C, Essers I, van den Bosch F, Dougados M, Etcheto A, van der Heijde D, Landewé R, Molto A, van Tubergen A, Boonen A.

Rheumatology (Oxford). 2019 Oct 26. pii: kez482. doi: 10.1093/rheumatology/kez482. [Epub ahead of print]

PMID:
31665462
15.

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.

Winthrop KL, Weinblatt ME, Bathon J, Burmester GR, Mease PJ, Crofford L, Bykerk V, Dougados M, Rosenbaum JT, Mariette X, Sieper J, Melchers F, Cronstein BN, Breedveld FC, Kalden J, Smolen JS, Furst D.

Ann Rheum Dis. 2020 Jan;79(1):88-93. doi: 10.1136/annrheumdis-2019-216151. Epub 2019 Oct 29. Review.

16.

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis.

Kiltz U, Landewé RBM, van der Heijde D, Rudwaleit M, Weisman MH, Akkoc N, Boonen A, Brandt J, Carron P, Dougados M, Gossec L, Jongkees M, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Niederman K, Sampaio-Barros PD, Slobodin G, Van den Bosch FE, van Tubergen A, van Weely S, Wiek D, Braun J.

Ann Rheum Dis. 2020 Feb;79(2):193-201. doi: 10.1136/annrheumdis-2019-216034. Epub 2019 Oct 11.

17.

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.

Rondaan C, Furer V, Heijstek MW, Agmon-Levin N, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, van Assen S, Elkayam O.

RMD Open. 2019 Sep 9;5(2):e001035. doi: 10.1136/rmdopen-2019-001035. eCollection 2019.

18.

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases.

Najm A, Nikiphorou E, Kostine M, Richez C, Pauling JD, Finckh A, Ritschl V, Prior Y, Balážová P, Stones S, Szekanecz Z, Iagnocco A, Ramiro S, Sivera F, Dougados M, Carmona L, Burmester G, Wiek D, Gossec L, Berenbaum F.

RMD Open. 2019 Sep 13;5(2):e001014. doi: 10.1136/rmdopen-2019-001014. eCollection 2019.

19.

Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort.

Sepriano A, Ramiro S, FitzGerald O, Østergaard M, Homik J, van der Heijde D, Elkayam O, Thorne JC, Larché MJ, Ferraccioli G, Backhaus M, Burmester GR, Boire G, Combe B, Schaeverbeke T, Saraux A, Dougados M, Rossini M, Govoni M, Sinigaglia L, Cantagrel A, Barnabe C, Bingham CO 3rd, Tak PP, van Schaardenburg D, Berner Hammer H, Paschke J, Dadashova R, Hutchings E, Landewé R, Maksymowych WP.

J Rheumatol. 2019 Sep 15. pii: jrheum.190303. doi: 10.3899/jrheum.190303. [Epub ahead of print]

PMID:
31523049
20.

Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA.

Maksymowych WP, FitzGerald O, Østergaard M, Homik J, van der Heijde D, Lambert RG, Elkayam O, Ramiro S, Thorne JC, Larché MJ, Ferraccioli G, Backhaus M, Burmester GR, Boire G, Combe B, Schaeverbeke T, Saraux A, Dougados M, Rossini M, Govoni M, Sinigaglia L, Cantagrel A, Barnabe C, Bingham CO 3rd, Tak PP, van Schaardenburg D, Berner Hammer H, Paschke J, Dadashova R, Hutchings E, Sepriano A, Landewé R.

J Rheumatol. 2019 Sep 1. pii: jrheum.190302. doi: 10.3899/jrheum.190302. [Epub ahead of print]

PMID:
31474600
21.

Could a methotrexate blood assay improve adherence?

Dougados M.

Nat Rev Rheumatol. 2019 Oct;15(10):577-578. doi: 10.1038/s41584-019-0291-x. No abstract available.

PMID:
31462728
22.

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, de Thurah A, Landewé RB, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

Ann Rheum Dis. 2020 Jan;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882. Epub 2019 Aug 14.

PMID:
31413005
23.

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts.

Boel A, Molto A, van der Heijde D, Ciurea A, Dougados M, Gensler LS, Santos MJ, De Miguel E, Poddubnyy D, Rudwaleit M, van Tubergen A, van Gaalen FA, Ramiro S.

Ann Rheum Dis. 2019 Nov;78(11):1545-1549. doi: 10.1136/annrheumdis-2019-215707. Epub 2019 Jul 30.

24.

Self-reported competencies and educational needs of rheumatology nurses: Results of a national survey.

Beauvais C, Gossec L, Mulliez A, Fayet F, Poilverd RM, Pouplin S, Perrot S, L'amour C, Carton L, Aubert MP, Miconnet S, Grange L, Flipon-Cousin E, Mézieres M, Dougados M, Jaccaz-Vallée N, Savel C.

Joint Bone Spine. 2020 Jan;87(1):91-93. doi: 10.1016/j.jbspin.2019.06.010. Epub 2019 Jul 4. No abstract available.

PMID:
31279742
25.

Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients.

Gossec L, Soubrier M, Foissac F, Molto A, Richette P, Beauvais C, Ruyssen-Witrand A, Perdriger A, Chary-Valckenaere I, Mouterde G, Dernis E, Euller-Ziegler L, Flipo RM, Gilson M, Guis S, Mariette X, Pouplin S, Marhadour T, Schaeverbeke T, Sordet C, Fayet F, Dougados M.

RMD Open. 2019 Jun 14;5(2):e000914. doi: 10.1136/rmdopen-2019-000914. eCollection 2019.

26.

Evaluation of the performances of 'typical' imaging abnormalities of axial spondyloarthritis: results of the cross-sectional ILOS-DESIR study.

Molto A, Gossec L, Lefèvre-Colau MM, Foltz V, Beaufort R, Laredo JD, Richette P, Dieude P, Goupille P, Feydy A, Dougados M.

RMD Open. 2019 May 28;5(1):e000918. doi: 10.1136/rmdopen-2019-000918. eCollection 2019.

27.

Novel DMARD monotherapy in rheumatoid arthritis.

Moltó A, Dougados M.

Lancet. 2019 Jun 8;393(10188):2277-2278. doi: 10.1016/S0140-6736(19)30768-8. Epub 2019 Jun 6. No abstract available.

PMID:
31180015
28.

Comorbidities in spondyloarthritis including psoriatic arthritis.

Moltó A, Dougados M.

Best Pract Res Clin Rheumatol. 2018 Jun;32(3):390-400. doi: 10.1016/j.berh.2018.09.002. Epub 2018 Nov 15.

PMID:
31171310
29.

Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort.

López-Medina C, Dougados M, Ruyssen-Witrand A, Moltó A.

Arthritis Res Ther. 2019 Jun 6;21(1):139. doi: 10.1186/s13075-019-1927-6.

30.

Effect of Gut Involvement in Patients with High Probability of Early Spondyloarthritis: Data from the DESIR Cohort.

Wendling D, Guillot X, Prati C, Miceli-Richard C, Molto A, Lories R, Dougados M.

J Rheumatol. 2019 Jun 1. pii: jrheum.181326. doi: 10.3899/jrheum.181326. [Epub ahead of print]

PMID:
31154418
31.

Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study.

López-Medina C, Moltó A, Dougados M.

J Rheumatol. 2020 Feb;47(2):211-217. doi: 10.3899/jrheum.181331. Epub 2019 Apr 15.

PMID:
30988127
32.

Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?

van Lunteren M, van der Heijde D, Sepriano A, Berg IJ, Dougados M, Gossec L, Jacobsson L, Ramonda R, Rudwaleit M, Sieper J, Landewé R, van Gaalen FA.

Rheumatology (Oxford). 2019 Sep 1;58(9):1649-1654. doi: 10.1093/rheumatology/kez095.

33.

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients.

Gossec L, Fayet F, Soubrier M, Foissac F, Molto A, Richette P, Beauvais C, Ruyssen-Witrand A, Perdriger A, Chary-Valckenaere I, Mouterde G, Dernis E, Euller-Ziegler L, Flipo RM, Gilson M, Balandraud N, Mariette X, Pouplin S, Marhadour T, Schaeverbeke T, Sordet C, Dougados M.

Rheumatology (Oxford). 2019 Aug 1;58(8):1498-1499. doi: 10.1093/rheumatology/kez094. No abstract available.

PMID:
30915463
34.

Percentage of progressors in imaging: can we ignore regressors?

Sepriano A, Ramiro S, Landewé R, Dougados M, van der Heijde D.

RMD Open. 2019 Feb 26;5(1):e000848. doi: 10.1136/rmdopen-2018-000848. eCollection 2019.

35.

Measuring spinal mobility in early axial spondyloarthritis: does it matter?

Marques ML, Ramiro S, Goupille P, Dougados M, van Gaalen F, van der Heijde D.

Rheumatology (Oxford). 2019 Sep 1;58(9):1597-1606. doi: 10.1093/rheumatology/kez026.

PMID:
30879078
36.

Evaluation of the Implementation of Guidelines on the Treatment of Osteoporosis in Patients with Rheumatoid Arthritis.

Malochet-Guinamand S, Lambert C, Gossec L, Soubrier M, Dougados M.

J Rheumatol. 2020 Jan;47(1):6-14. doi: 10.3899/jrheum.180889. Epub 2019 Mar 15.

PMID:
30877214
37.

Evaluation of the predictive validity of the ASAS axial spondyloarthritis criteria in the DESIR cohort.

Meghnathi B, Saraux A, Dougados M, Moltó A.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):797-802. Epub 2019 Mar 7.

PMID:
30873948
38.

Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib.

Combe B, Balsa A, Sarzi-Puttini P, Tony HP, de la Torre I, Rogai V, Durand F, Witt S, Zhong J, Dougados M.

Ann Rheum Dis. 2019 Aug;78(8):1135-1138. doi: 10.1136/annrheumdis-2018-214261. Epub 2019 Mar 6. No abstract available.

39.

Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain.

Puyraimond-Zemmour D, Granger B, Molto A, Gaujoux-Viala C, Guillemin F, Ruyssen-Witrand A, Dougados M, Fautrel B, Gossec L.

Arthritis Res Ther. 2019 Feb 19;21(1):63. doi: 10.1186/s13075-019-1841-y.

40.

Clinical Characteristics of Patients with Spondyloarthritis in Japan in Comparison with Other Regions of the World.

Kishimoto M, Yoshida K, Ichikawa N, Inoue H, Kaneko Y, Kawasaki T, Matsui K, Morita M, Suda M, Tada K, Takizawa N, Tamura N, Taniguchi A, Taniguchi Y, Tsuji S, Haji Y, Rokutanda R, Yanaoka H, Cheung PP, Gu J, Kim TH, Luo SF, Okada M, López Medina C, Molto A, Dougados M, Kobayashi S, van der Heijde D, Tomita T.

J Rheumatol. 2019 Aug;46(8):896-903. doi: 10.3899/jrheum.180412. Epub 2019 Feb 15.

PMID:
30770497
41.

Response to 'Everything we see is a perspective, not the truth' by Chattopadhyay et al.

Molto A, Sahuguet J, Fechtenbaum J, Etcheto A, López-Medina C, Richette P, Dougados M, Roux C, Briot K.

Ann Rheum Dis. 2019 Feb 13. pii: annrheumdis-2019-215131. doi: 10.1136/annrheumdis-2019-215131. [Epub ahead of print] No abstract available.

PMID:
30760473
42.

Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis.

Fogel O, Bugge Tinggaard A, Fagny M, Sigrist N, Roche E, Leclere L, Deleuze JF, Batteux F, Dougados M, Miceli-Richard C, Tost J.

Arthritis Res Ther. 2019 Feb 12;21(1):51. doi: 10.1186/s13075-019-1829-7.

43.

Assessment of the adherence to disease-modifying drugs in patients with chronic inflammatory rheumatic diseases: Results of a survey of 1594 patients.

López-Medina C, Moltó A, Gérald F, Dubremetz M, Grange L, Thibaud G, Charles B, Lafarge D, Beauvais C, Gossec L, Dougados M.

Joint Bone Spine. 2019 Oct;86(5):610-614. doi: 10.1016/j.jbspin.2019.01.023. Epub 2019 Feb 7.

PMID:
30738192
44.

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018.

Winthrop KL, Weinblatt ME, Crow MK, Burmester GR, Mease PJ, So AK, Bykerk V, Van Vollenhoven RF, Dougados M, Kay J, Mariette X, Sieper J, Melchers F, Cronstein BN, Shevach E, Breedfeld FC, Kalden J, Smolen JS, Furst DE.

Ann Rheum Dis. 2019 Jul;78(7):872-878. doi: 10.1136/annrheumdis-2018-214280. Epub 2019 Feb 2. Review.

PMID:
30712015
45.

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study.

Gottenberg JE, Morel J, Perrodeau E, Bardin T, Combe B, Dougados M, Flipo RM, Saraux A, Schaeverbeke T, Sibilia J, Soubrier M, Vittecoq O, Baron G, Constantin A, Ravaud P, Mariette X; French Society of Rheumatology and the investigators participating in AIR, ORA, and REGATE registries.

BMJ. 2019 Jan 24;364:l67. doi: 10.1136/bmj.l67.

46.

Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA).

Putrik P, Ramiro S, Moltó A, Keszei AP, Norton S, Dougados M, van der Heijde D, Landewé RBM, Boonen A.

Ann Rheum Dis. 2019 Apr;78(4):486-493. doi: 10.1136/annrheumdis-2018-214259. Epub 2019 Jan 23.

PMID:
30674477
47.

Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort.

Nadon V, Moltó A, Etcheto A, Bessette L, Michou L, D'Agostino MA, Claudepierre P, Wendling D, Haraoui P, Dougados M.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):561-565. Epub 2018 Dec 19.

PMID:
30620273
48.

Acute anterior uveitis in spondyloarthritis: a monocentric study of 301 patients.

Frantz C, Portier A, Etcheto A, Monnet D, Brezin A, Roure F, Elhai M, Burki V, Fabreguet I, Koumakis E, Payet J, Gossec L, Dougados M, Molto A.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):26-31. Epub 2018 Dec 19.

49.

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.

Webers C, Ramiro S, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A, Boonen A.

RMD Open. 2018 Nov 27;4(2):e000766. doi: 10.1136/rmdopen-2018-000766. eCollection 2018.

50.

Is active sacroiliitis on MRI associated with radiographic damage in axial spondyloarthritis? Real-life data from the ASAS and DESIR cohorts.

Sepriano A, Ramiro S, Landewé R, Dougados M, van der Heijde D, Rudwaleit M.

Rheumatology (Oxford). 2019 May 1;58(5):798-802. doi: 10.1093/rheumatology/key387.

PMID:
30544144

Supplemental Content

Loading ...
Support Center